|
ANKRD56 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.6377002238529E-10 |
| Normal-vs-Stage2 |
2.51950016405544E-10 |
| Normal-vs-Stage3 |
1.49730006171467E-10 |
| Normal-vs-Stage4 |
6.69590000001996E-07 |
| Stage1-vs-Stage2 |
5.010000E-01 |
| Stage1-vs-Stage3 |
5.314400E-01 |
| Stage1-vs-Stage4 |
2.241800E-01 |
| Stage2-vs-Stage3 |
8.858800E-01 |
| Stage2-vs-Stage4 |
4.385000E-01 |
| Stage3-vs-Stage4 |
3.479800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.37859953955422E-10 |
| Normal-vs-Asian |
6.63340005147006E-09 |
| Caucasian-vs-AfricanAmerican |
6.033200E-01 |
| Caucasian-vs-Asian |
1.020040E-01 |
| AfricanAmerican-vs-Asian |
4.116400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3466996668684E-10 |
| Normal-vs-Female |
1.89890325685838E-11 |
| Male-vs-Female |
5.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.37599997641314E-11 |
| Normal-vs-Extreme_Weight |
1.65456537359887E-12 |
| Normal-vs-Obese |
2.4882995663944E-10 |
| Normal-vs-Extreme_Obese |
6.06020000000207E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.504800E-01 |
| Normal_Weight-vs-Obese |
8.388600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.824000E-01 |
| Extreme_Weight-vs-Obese |
7.240600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.921800E-01 |
| Obese-vs-Extreme_Obese |
5.961600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.66299999513487E-08 |
| Normal-vs-Age(41-60Yrs) |
4.80509965150588E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.66729999998105E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.222200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.534200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.181600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.460200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.460200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.406000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.969800126986E-10 |
| Normal-VS-Type2 PRCC |
4.85020024143523E-10 |
| Normal-VS-KIRP CIMP |
8.33540000000355E-05 |
| Normal-VS-Unclassified PRCC |
6.07970340738007E-11 |
| Type1 PRCC-VS-Type2 PRCC |
9.570200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.450000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.678200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.783400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.190200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.181000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02180486294401E-11 |
| Normal-vs-N1 |
2.00319760779166E-11 |
| Normal-vs-N2 |
2.536400E-03 |
| N0-vs-N1 |
9.436400E-01 |
| N0-vs-N2 |
9.817000E-01 |
| N1-vs-N2 |
9.460600E-01 |
|
|
